| __timestamp | Exelixis, Inc. | Genmab A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 25111000 | 850385000 |
| Thursday, January 1, 2015 | 37172000 | 1133041000 |
| Friday, January 1, 2016 | 191454000 | 1816122000 |
| Sunday, January 1, 2017 | 452477000 | 2365436000 |
| Monday, January 1, 2018 | 853826000 | 3025137000 |
| Tuesday, January 1, 2019 | 967775000 | 5366000000 |
| Wednesday, January 1, 2020 | 987538000 | 10111000000 |
| Friday, January 1, 2021 | 1434970000 | 8482000000 |
| Saturday, January 1, 2022 | 1611062000 | 14595000000 |
| Sunday, January 1, 2023 | 1830208000 | 16474000000 |
| Monday, January 1, 2024 | 2168701000 | 21526000000 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and market influence. Over the past decade, Genmab A/S and Exelixis, Inc. have demonstrated remarkable financial trajectories. From 2014 to 2023, Genmab A/S has seen its revenue soar by nearly 1,800%, reaching a peak of approximately $16.5 billion in 2023. This Danish biotech powerhouse has consistently outpaced its American counterpart, Exelixis, Inc., which, despite a commendable 7,200% increase, reached a revenue of $1.8 billion in the same year.
The data reveals a compelling narrative of growth and resilience, with Genmab A/S maintaining a dominant position. As the biotech industry continues to evolve, these companies exemplify the potential for innovation-driven revenue expansion.
Pfizer Inc. vs Genmab A/S: Examining Key Revenue Metrics
Vertex Pharmaceuticals Incorporated or Exelixis, Inc.: Who Leads in Yearly Revenue?
Takeda Pharmaceutical Company Limited and Exelixis, Inc.: A Comprehensive Revenue Analysis
Alnylam Pharmaceuticals, Inc. vs Exelixis, Inc.: Examining Key Revenue Metrics
Revenue Insights: Biogen Inc. and Exelixis, Inc. Performance Compared
Comparing Revenue Performance: Genmab A/S or Walgreens Boots Alliance, Inc.?
Revenue Showdown: Genmab A/S vs Corcept Therapeutics Incorporated
Who Generates More Revenue? Genmab A/S or Vericel Corporation
Exelixis, Inc. and Ionis Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Comparing Revenue Performance: Exelixis, Inc. or Arrowhead Pharmaceuticals, Inc.?
Revenue Insights: Exelixis, Inc. and ImmunityBio, Inc. Performance Compared
Exelixis, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared